Commissioning groups to get help from private firms

Several private companies have been approved to provide support services to NHS in England as part of a new procurement procedure.
Through the Commissioning Support Lead Provider Framework and what the NHS calls a ‘rigorous’ process, it has identified a host of third party firms to …

More details...

Seven new medicines recommended for European approval

Includes antibiotics treatments and medicines for haemostasis and HIV
Seven new medicines have been recommended for approval at the January 2015 meeting of the Committee for Medicinal Products for Human Use (CHMP).
The committee, which is the safety and efficacy arm of the EMA, has recommended granting …

More details...

NICE recommends rivaroxaban to prevent blood clots in heart attack patients

Extends the pill’s growing list of NICE recommendations
In final draft guidance published this week NICE is recommending rivaroxaban (Xarelto, Bayer Healthcare), in combination with clopidogrel and aspirin, or with aspirin alone, as an option for preventing blood clots in people who have had an acute …

More details...

New anti-obesity drug recommended in Europe

A high dose form of liraglutide has been backed by the CHMP
The European Medicines Agency has recommended granting a marketing authorisation for liraglutide (Saxenda, Novo Nordisk) for weight management in overweight or obese adults.
The medicine is recommended for use in addition to a reduced-calorie diet …

More details...

NICE set to recommend type 2 diabetes drug empagliflozin

Pill will sit alongside an arsenal of other sugar-lowering medicines
NICE has issued further draft guidance which recommends empagliflozin, marketed by Boehringer Ingelheim, for treating type 2 diabetes.
In a preliminary appraisal last August, NICE called for the company to provide more evidence to demonstrate that empagliflozin …

More details...

Apremilast approved in Europe for psoriasis

The new treatment can also be used for psoriatic arthritis patients
New treatment apremilast (Otezla) has been approved by the European Commission for the treatment of patients with psoriasis and psoriatic arthritis.
The drug, a selective PDE4 inhibitor, is the first oral treatment in 20 years to …

More details...

Hepatitis C combination treatment approved in Europe

The all oral drug regimen should be launched in the UK in the coming month
A new combination hepatitis C drug therapy has been given the green light by the European Commission, adding to a glut of new treatments for the disease.
The treatment, ombitasvir/paritaprevir/ritonavir (Viekirax, AbbVie) …

More details...

NICE yes for two new hepatitis C drugs

But NHS England has balked at the plans, saying it cannot afford to pay for sofosbuvir
NICE is now recommending that two new but costly hepatitis C pills should be funded by the NHS, but NHS England says it will not pay for sofosbuvir until later …

More details...

Long-acting diabetes drug dulaglutide launches in UK

A new type II diabetes medicine dulaglutide (Trulicity) has been launched in the UK this week.
The drug is a GLP-1 receptor agonist and works as a once-weekly, injectable solution designed to improve glycaemic control in adults with type 2 diabetes.
The treatment was given European approval …

More details...

Cancer Drug Fund succumbs to cuts

Sixteen medicines spanning 25 indications have been culled from the silo budget
The government’s flagship silo fund for new oncology medicines has buckled under the financial pressure of paying for expensive new cancer drugs, and has announce it will cut 16 medicines with 25 indications from …

More details...

Web design and marketing agency Leamington Spa